Cargando…

CD40 monoclonal antibody and OK432 synergistically promote the activation of dendritic cells in immunotherapy

BACKGROUND: Colorectal cancer (CRC) with pulmonary metastasis usually indicates a poor prognosis, whereas patients may benefit from adoptive cell therapy. Tumor-specific cytotoxic T lymphocytes (CTLs) have been reported as a promising treatment for CRC. However, the antitumor effect of CTLs remains...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Juan, Wang, Lei, Li, Shuyi, Gao, Xuefeng, Liu, Zhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9206283/ https://www.ncbi.nlm.nih.gov/pubmed/35715855 http://dx.doi.org/10.1186/s12935-022-02630-x

Ejemplares similares

Percutaneous Treatment of Renal Cysts with OK-432 Sclerosis
por: Choi, Young Deuk, et al.
Publicado: (2007)

OK-432 Treatment of Ranula Intruding into the Cervical Region
por: Ohta, Nobuo, et al.
Publicado: (2022)

The Soluble Factor from Oral Cancer Cell Lines Inhibits Interferon-γ Production by OK-432 via the CD40/CD40 Ligand Pathway
por: Ohe, Go, et al.
Publicado: (2021)

Picibanil (OK-432) in the treatment of head and neck lymphangiomas in children
por: Rebuffini, Elena, et al.
Publicado: (2012)

Successful pleurodesis with OK-432 in preterm infants with persistent pleural effusion
por: Kim, Jeong Eun, et al.
Publicado: (2012)

OK432 sclerotherapy for refractory chylous leakage after neck dissection
por: Hashimoto, Yuiko, et al.
Publicado: (2023)

Efficacy of OK-432 sclerotherapy for different types of lymphangiomas: a review and meta-analysis
por: Sun, Jiali, et al.
Publicado: (2023)

The prognostic advantage of preoperative intratumoral injection of OK-432 for gastric cancer patients
por: Gochi, A, et al.
Publicado: (2001)

Chemokines are secreted by monocytes following OK-432 (lyophilized Streptococcus pyogenes) stimulation
por: Olsnes, Carla, et al.
Publicado: (2009)

Risk Factors for Chest Pain and Fever in Patients Undergoing Pleurodesis with OK-432
por: Morimoto, Yoshihito, et al.
Publicado: (2018)

Response to OK-432 sclerotherapy in the treatment of cervical lymphangioma with submucosal extension to the airway()
por: Manzini, Michelle, et al.
Publicado: (2016)

Immunotherapy with Subcutaneous Injection of Immunomodulatory Agent (OK-432) Elicits Durable Response in Locally Advanced or Relapsed Cervical Cancer
por: Alas, Quenny Michelle Dyan A., et al.
Publicado: (2019)

Injectable hydrogel loaded with lysed OK-432 and doxorubicin for residual liver cancer after incomplete radiofrequency ablation
por: Cao, Yanyan, et al.
Publicado: (2023)

Interferon-α-inducible Dendritic Cells Matured with OK-432 Exhibit TRAIL and Fas Ligand Pathway-mediated Killer Activity
por: Koya, Terutsugu, et al.
Publicado: (2017)

Safety and Long-Term Outcome of Intratumoral Injection of OK432-Stimulated Dendritic Cells for Hepatocellular Carcinomas After Radiofrequency Ablation
por: Kitahara, Masaaki, et al.
Publicado: (2020)

Correction: Injectable hydrogel loaded with lysed OK-432 and doxorubicin for residual liver cancer after incomplete radiofrequency ablation
por: Cao, Yanyan, et al.
Publicado: (2023)

Maturation of monocyte derived dendritic cells with OK432 boosts IL-12p70 secretion and conveys strong T-cell responses
por: Hovden, Arnt-Ove, et al.
Publicado: (2011)

Successful treatment of hepatic lymphorrhea by percutaneous transhepatic lymphangiography followed by sclerotherapy using OK-432
por: Kojima, Masayuki, et al.
Publicado: (2019)

Percutaneous sclerotherapy with OK-432 for lymphocele after pelvic or para-aortic lymphadenectomy: preliminary results
por: Kashiwagi, Eiji, et al.
Publicado: (2022)

Effects of programmed death-ligand 1 expression on OK-432 immunotherapy following transurethral resection in non-muscle invasive bladder cancer
por: Liu, Zhi-Hua, et al.
Publicado: (2017)

The Bacterial Preparation OK432 Induces IL-12p70 Secretion in Human Dendritic Cells in a TLR3 Dependent Manner
por: Hovden, Arnt-Ove, et al.
Publicado: (2012)

The Changing Pattern of the Splenic Lymphocyte Subsets in Tumor‐bearing Mice after Oral Treatment with OK‐432
por: Akamatsu, Yoshihiko, et al.
Publicado: (1992)

OK-432 Acts as Adjuvant to Modulate T Helper 2 Inflammatory Responses in a Murine Model of Asthma
por: Wu, Cheng-Jang, et al.
Publicado: (2018)

The usefulness of OK‐432 for the treatment of postoperative chylothorax in a low‐birth‐weight infant with trisomy 18
por: Takahashi, Yoshiaki, et al.
Publicado: (2022)

Treatment of lymphangiomas by means of sclerotherapy with OK-432 (Picibanil®) is safe and effective – A retrospective case series
por: Fasching, G., et al.
Publicado: (2022)

Promising abscopal effect of combination therapy with thermal tumour ablation and intratumoural OK-432 injection in the rat osteosarcoma model
por: Iwai, Tadashi, et al.
Publicado: (2020)

Locoregional immunotherapy of malignant effusion from colorectal cancer using the streptococcal preparation OK-432 plus Interleukin-2: Induction of autologous tumour-reactive CD4+ Th1 killer lymphocytes
por: Yamaguchi, Y, et al.
Publicado: (2003)

Circular RNA CDR1as promotes tumor progression by regulating miR-432-5p/E2F3 axis in pancreatic cancer
por: Xiong, Xingcheng, et al.
Publicado: (2021)

Localization of CD26/DPPIV in nucleus and its nuclear translocation enhanced by anti-CD26 monoclonal antibody with anti-tumor effect
por: Yamada, Kohji, et al.
Publicado: (2009)

Efficacy of Dendritic Cells Matured Early with OK-432 (Picibanil®), Prostaglandin E(2), and Interferon-α as a Vaccine for a Hormone Refractory Prostate Cancer Cell Line
por: Yoo, Changhee, et al.
Publicado: (2010)

OK-432 Administration Inhibits Murine Allergic Rhinitis at the Induction Phase, through the Macrophage Activation with TLR2 Signaling Pathway
por: Aoi, Noriaki, et al.
Publicado: (2018)

Comparison of the Efficacy and Safety of Single-Session OK-432 and Multiple-Session 99% Ethanol Sclerotherapy for Symptomatic Simple Hepatic Cysts
por: Mo, Zhiqiang, et al.
Publicado: (2022)

A Case of Sublingual Ranula That Responded Successfully to Localized Injection Treatment with OK-432 after Healing from Drug Induced Hypersensitivity Syndrome
por: Yoshizawa, Kunio, et al.
Publicado: (2016)

Microwave ablation combined with OK-432 induces Th1-type response and specific antitumor immunity in a murine model of breast cancer
por: Li, Li, et al.
Publicado: (2017)

The Cytocidal Activity of OK‐432‐activated Mononuclear Cells against Human Glioma Cells is Partly Mediated through the Fas Ligand/Fas System
por: Toda, Keisuke, et al.
Publicado: (1996)

Synergistic immunotherapy of glioblastoma by dual targeting of IL-6 and CD40
por: Yang, Fan, et al.
Publicado: (2021)

I'm OK, you're OK
por: Harris, Thomas A
Publicado: (2004)

LINC01783 facilitates cell proliferation, migration and invasion in non-small cell lung cancer by targeting miR-432-5p to activate the notch pathway
por: Deng, Yanchao, et al.
Publicado: (2021)

A humanized anti-CD26 monoclonal antibody inhibits cell growth of malignant mesothelioma via retarded G2/M cell cycle transition
por: Hayashi, Mutsumi, et al.
Publicado: (2016)

Characterization of mouse natural killer cell activating factor (NKAF) induced by OK-432: evidence for interferon- and interleukin 2-independent NK cell activation.
por: Ichimura, O., et al.
Publicado: (1984)

Cannot write session to /tmp/vufind_sessions/sess_hvtosagpjeqbc40v8vv72cv8gb